UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
or

Metagenomi Inc (MGX)

Metagenomi Inc (MGX)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
1.4300 +0.0200 (+1.42%) 04/07/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 1.4500 +0.0200 (+1.40%) 19:31 ET
News & Headlines for Mon, Apr 7th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Metagenomi Reports Business Updates and Full Year 2024 Financial Results

MGX : 1.4300 (+1.42%)
Mineralys, Tenaya, SpringWorks, COSCIENS, Metagenomi: 5 Biotech Stocks That Led Retail Follower Growth Last Week

Positive data from clinical trials, earnings readouts, M&A speculation and new research drew heavy interest from retail traders on Stocktwits for these tickers for the week ended March 14, 2025.

TNYA : 0.4801 (-3.75%)
CSCI : 2.43 (-5.09%)
MLYS : 12.05 (-2.82%)
SWTX : 36.99 (-5.37%)
MGX : 1.4300 (+1.42%)
Metagenomi Announces Publication in Nature Communications on Large Gene Integration Advances Using Novel, Compact CRISPR-associated transposase (CAST) Systems

MGX : 1.4300 (+1.42%)
Metagenomi to Present at TD Cowen's 45th Annual Health Care Conference

MGX : 1.4300 (+1.42%)
Stargate, Netflix, GE Aerospace, Twilio, and More

There's a lot for investors to talk about.

NFLX : 867.83 (+1.40%)
META : 516.25 (+2.28%)
GOOGL : 146.75 (+0.79%)
NVDA : 97.64 (+3.53%)
GOOG : 149.24 (+1.02%)
TWLO : 83.71 (+0.16%)
ATEN : 14.91 (-0.13%)
F : 9.24 (-3.55%)
JPM : 214.44 (+1.98%)
RKLB : 17.52 (+7.03%)
NKE : 55.61 (-2.86%)
ORCL : 127.16 (-0.87%)
Metagenomi Highlights Progress Across Therapeutic Portfolio and Outlines Anticipated Milestones

MGX : 1.4300 (+1.42%)
Metagenomi Announces New Appointment to its Board of Directors

MGX : 1.4300 (+1.42%)
Metagenomi to Present at the 43rd Annual J.P. Morgan Healthcare Conference

MGX : 1.4300 (+1.42%)
2 ‘Monster’ Stocks to Snap Up Before 2025

Analysts at Jefferies have identified Metagenomi and Structure Therapeutics as two "monster" stocks in the biotech sector, with potential gains of up to 1,000%.

GPCR : 14.31 (-5.36%)
MGX : 1.4300 (+1.42%)
Metagenomi Presents Highly Specific and Efficient Genome Editing Tools at Nature Conference “RNA at the Bench and Bedside IV”

MGX : 1.4300 (+1.42%)

Barchart Exclusives

Bank of America Says This 1 Dividend Stock Is a Top Buy for Q2
Bank of America has named Energy Transfer as a top dividend stock for Q2 2025, citing its strong financials, strategic growth initiatives, and attractive 8% forward dividend yield. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trader's Cheat Sheet: Your Secret Weapon for Smarter Trades